Health
UPDATE North Riverdale: 31-Year-Old Man Reported Missing Later Located
Gillibrand Condemns Rape & Sexual Violence by Hamas Against Israelis, Calls Out UN Women for Silence
U.S. Sen. Kirsten Gillibrand delivered remarks at a special session convened by Israel’s Permanent Mission to the U.N. on Monday, Dec. 4. At the session, Gillibrand and other women’s rights experts denounced the use of rape and sexual violence committed by Hamas terrorists against Israeli women and girls. The senator’s full remarks can be read below.
Hunts Point: Police Appeal for Help Locating Missing 74-Year-old Nun
Edenwald: Police Appeal for Help Locating 33-Year-Old Woman Reported Missing
NYC Health + Hospitals Reminds New Yorkers of Guaranteed Healthcare Program: “NYC Care”
NYC Health + Hospitals’ NYC Care program has launched a public awareness campaign to encourage eligible New Yorkers to enroll in its guaranteed healthcare program. They are doing so, officials said to ensure New Yorkers can “access the primary, preventive, and specialty care needed to lead longer, healthier lives.”
UPDATE NYS Cannabis Control Board to Hold Public Board Meeting on Friday, Dec. 8, Court Rules Applications Can Continue
The New York State Cannabis Control Board will hold a public board meeting on Friday, Dec. 8, at 10.30 a.m. at Empire State Plaza Convention Center, Meeting Rooms 6, Albany, NY 12242. Members of the public are invited to comment, should they wish to do so. The event will also be livestreamed. Meanwhile, a court has lifted an injunction, put in place since August 2023, to allow the Office of Cannabis Management (OCM) to continue reviewing applications for Conditional Adult Use Retail Dispensary (CAURD) licenses.
UPDATE Morris Heights: 77-Year-Old Bronx Resident Reported Missing Now Found
Montefiore Einstein Awarded FDA Grant for Clinical Trial on Experimental Blood Cancer Treatment
Two related blood cancers that disproportionally target older adults called acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), are notoriously difficult to treat and are associated with high relapse rates, according to medical experts at Montefiore Einstein Comprehensive Cancer Center (MECCC). Although new therapies have improved survival rates, they say treatment options remain limited, and the prognosis for the 50% of people who have these cancers, remains poor.
